Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications

The goal of personalized medicine is to target the right treatments to the right patients at the right time. Patients with a variety of cancers and other complex diseases are regularly tested as part of patient care, enabling physicians to personalize patient monitoring and treatment. Among the soug...

Full description

Bibliographic Details
Main Author: Lucia Napione
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/11/9/2362
id doaj-2e3d7da6f6c740fa8a1ea61025699e4c
record_format Article
spelling doaj-2e3d7da6f6c740fa8a1ea61025699e4c2021-09-26T00:49:00ZengMDPI AGNanomaterials2079-49912021-09-01112362236210.3390/nano11092362Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine ApplicationsLucia Napione0Department of Applied Science and Technology, Politecnico di Torino, 10129 Torino, ItalyThe goal of personalized medicine is to target the right treatments to the right patients at the right time. Patients with a variety of cancers and other complex diseases are regularly tested as part of patient care, enabling physicians to personalize patient monitoring and treatment. Among the sought-after diagnostic tools, there is an increasing interest and need for those based on a low-cost, easy, rapid, and accurate method for the detection of specific circulating biomarkers above a detection threshold. Lateral flow tests (LFTs), enhanced by nanotechnology, can fulfil these requirements, providing a significant support to personalized patient monitoring. In this review, after a short historical synopsis of membrane-based lateral flow assays, including a description of a typical configuration of a LFT strip, a careful collection is presented of the best characterized nanotechnology approaches previously reported for the enhancement of target detection performance. The attempt is to offer an overview of currently integrated nanotechnologies in LFTs, fostering the actual future development of advantageous diagnostic devices for patient monitoring.https://www.mdpi.com/2079-4991/11/9/2362circulating biomarkersnanotechnological toolsfunctionalized surfacedevice
collection DOAJ
language English
format Article
sources DOAJ
author Lucia Napione
spellingShingle Lucia Napione
Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications
Nanomaterials
circulating biomarkers
nanotechnological tools
functionalized surface
device
author_facet Lucia Napione
author_sort Lucia Napione
title Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications
title_short Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications
title_full Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications
title_fullStr Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications
title_full_unstemmed Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications
title_sort integrated nanomaterials and nanotechnologies in lateral flow tests for personalized medicine applications
publisher MDPI AG
series Nanomaterials
issn 2079-4991
publishDate 2021-09-01
description The goal of personalized medicine is to target the right treatments to the right patients at the right time. Patients with a variety of cancers and other complex diseases are regularly tested as part of patient care, enabling physicians to personalize patient monitoring and treatment. Among the sought-after diagnostic tools, there is an increasing interest and need for those based on a low-cost, easy, rapid, and accurate method for the detection of specific circulating biomarkers above a detection threshold. Lateral flow tests (LFTs), enhanced by nanotechnology, can fulfil these requirements, providing a significant support to personalized patient monitoring. In this review, after a short historical synopsis of membrane-based lateral flow assays, including a description of a typical configuration of a LFT strip, a careful collection is presented of the best characterized nanotechnology approaches previously reported for the enhancement of target detection performance. The attempt is to offer an overview of currently integrated nanotechnologies in LFTs, fostering the actual future development of advantageous diagnostic devices for patient monitoring.
topic circulating biomarkers
nanotechnological tools
functionalized surface
device
url https://www.mdpi.com/2079-4991/11/9/2362
work_keys_str_mv AT lucianapione integratednanomaterialsandnanotechnologiesinlateralflowtestsforpersonalizedmedicineapplications
_version_ 1716869767679180800